Beyond fluconazole: A review of vulvovaginal candidiasis diagnosis and treatment
- PMID: 37643144
- DOI: 10.1097/01.NPR.0000000000000095
Beyond fluconazole: A review of vulvovaginal candidiasis diagnosis and treatment
Abstract
Vaginitis symptoms are among the most common reasons for patients to seek acute gynecological care. NPs who care for women and other patients with vaginas need to be up-to-date on diagnosis and treatment of vulvovaginal candidiasis (VVC) and recurrent VVC (RVVC). Two new antifungal medications for VVC are available. This article reviews vaginal physiology and provides an overview of VVC and RVVC pathophysiology, diagnosis, and treatment options.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Benedict K, Jackson BR, Chiller T, Beer KD. Estimation of direct healthcare costs of fungal diseases in the United States. Clin Infect Dis . 2019;68(11):1791–1797. doi:10.1093/cid/ciy776.
-
- Crandall CC. Menopause Practice: A Clinician's Guide . The North American Menopause Society; 2022.
-
- Gershenson DM, Lentz GM, Valea FA, Lobo RA. Comprehensive Gynecology . Elsevier - Health Sciences Division; 2022.
-
- Zhu Y-X, Li T, Fan S-R, Liu X-P, Liang Y-H, Liu P. Health-related quality of life as measured with the Short-Form 36 (SF-36) questionnaire in patients with recurrent vulvovaginal candidiasis. Health Qual Life Outcomes . 2016;14(1):65. doi:10.1186/s12955-016-0470-2.
-
- Ferris DG, Nyirjesy P, Sobel JD, Soper D, Pavletic A, Litaker MS. Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis. Obstet Gynecol . 2002;99(3):419–425. doi:10.1016/s0029-7844(01)01759-8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
